BrainScan Sp. z o. o.

zł 7.90As of Sun 8 Nov 2026, 12:00 UTC

WSE:BSNHealthcare

Country Poland

PE (Fwd) —

TSR 2Y CAGR (46.43%)

Div yield —

ROE —

Health Information Services

Beta (5Y) —

PE TTM —

TSR TTM (64.73%)

Mkt cap zł 10.06M

ROIC —

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

zł 8.63

9.21%

(75.33%)

Price above Reference Value

TTM

FYE 31 Dec PLN

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

0.322

Revenuezł M

—

0.056

0.214

0.194

0.307

86.74%

—

Revenue growth%

—

285.17

(9.46)

58.42

137.85

—

97.48

Gross margin%

—

6.98

74.87

91.05

100.00

74.87

—

(1298.73)

Operating margin%

—

(3755.23)

(2263.82)

(1527.22)

(100.00)

(2263.82)

—

(1337.05)

Net margin%

—

(3204.21)

(2395.01)

(1580.69)

(100.00)

(2395.01)

—

P/E ratio (avg)x

—

EV/EBITx

—

(31.00)

FCF yield (avg)%

—

(10.45)

(12.47)

(3.24)

(11.46)

—

(967.86)

FCF margin%

—

(3240.46)

(1822.14)

(1829.17)

(100.00)

(1829.17)

—

0.724

FCF / Net incomex

—

1.011

0.761

1.157

—

1.011

—

ROIC%

—

(322.00)

(9009.28)

—

(4665.64)

—

Return on equity%

—

(36.62)

(222.99)

—

(129.81)

—

(677.74)

Return on assets%

—

(33.54)

(822.90)

(120.64)

(63.71)

(120.64)

—

(3.38)

EPSzł

—

(1.52)

(4.39)

(2.55)

(0.26)

—

EPS growth%

—

(187.89)

41.82

89.98

(73.04)

—

(3.88)

Bookvalue per shzł

—

4.16

(0.23)

(2.17)

(4.25)

—

(2.45)

FCF per sharezł

—

(1.54)

(3.34)

(2.95)

(0.26)

—

Dividend per shzł

—

Div yield (avg)%

—

Payout ratio%

—

1.274

Shares (diluted)M

—

1.167

1.199

◌1.199

1.35%

—

Buyback yield%

—

(2.72)

◌—

(1.36)

—

D/E ratiox

—

7.651

Enterprise valuezł M

—

36.99

25.99

9.409

(29.72%)

—

LT debtzł M

—

Peers (US$2.329M)

Cap (US$)

Massmedica S.A.

2.683M

17.19x

Telemedycyna Polska…

2.008M

—

Private Rented Sector…

1.898M

—

Innovotech Inc.

2.312M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(57.16)

(192.4)

Own earn%

—

Sh yield%

—

(1.36)

Owners

Insiders/Inst%

—

3.00

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/3

Revenue growth years

—

EPS growth years

—

Dividend streakyrs

Op margin range%

−3755–−1527

$1 testx

—

Incr. ROIC%

—

BrainScan Sp. z o. o. Engages in the development of a brain scanning system intended to provide digital imaging diagnostics in a form of infographics. The company's system utilizes artificial intelligence, which facilitates automatic detection and classification of pathological changes occurring in CT examinations of the brain, enabling doctors to get additional information that allows for efficient interpretations.

Growth vs revenue

Latest

Trend

2Y CAGR

Rel growth

Revenue

zł 0.194M

86.74%

1.00×

Cost of revenue

zł 0.017M

(42.08%)

0.10×

Operating expenses

zł 3.132M

22.48%

0.43×

Asset mix

Trend

Cash and investments

95.08%

Other

4.92%

Reinvestment returns

No breakdown available